The results directly demonstrated the involvement of HSF2 in colorectal cancer, renal cell carcinoma, hepatocellular carcinoma, endometrial cancer, small cell lung cancer, chronic myeloid leukemia, and viral carcinogenesis (Figures 6, 7). The gene discussed is HSF2; the disease is hepatocellular carcinoma.